Clinical Trials Browser

Phase 2 × Carcinoma, Squamous Cell × Bevacizumab × Clear all

NCT00409565 2017-10-20

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

48 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00130780 2016-01-25

Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Phase 2 Completed

71 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell